David Gaugh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Here’s our list of the experts and advocates, outside the government, who are playing big roles in Washington’s policy debates.

The shortage of life-sustaining drugs for cancer, diabetes, and ADHD that has plagued hospitals and patients for years has now reached its peak with 323 medicines officially in short supply.

The Biosimilars Council released a new analysis by IQVIA that reveals a PBM strategy to protect $2 billion in profits by “strangling” the biosimilar market and preventing savings for patients.

An Avalere analysis found that fewer than half of all generic drugs are on generic formulary tiers.

The organization noted that the 1984 law has enabled trillions of dollars in savings, but the industry is at risk.